The study was stopped early to allow all patients with advanced PAH the option for treatment with the activin signaling ...

A multistate model that enables real-time risk recalculations may help improve risk stratification for prediction of ...

Investigators saw more deaths in patients with severe TR after repeat mitral valve procedures; what to do about it is unclear ...

LONDON, ENGLAND—Clinical and echocardiographic outcomes with the latest-generation balloon-expandable Sapien 3 Ultra Resilia ...

The preliminary data open the door to an alternative approach to invasive monitoring in heart failure patients.

Acoramidis becomes the second drug ever approved for this condition, based on the results of the ATTRibute-CM trial.

Much remains to learn about this anatomical finding, seen in about one-third of adults, and how it may affect stroke risk.

These data should help reassure those concerned with the risks of educating physicians through live cases at medical meetings ...

Compared with placebo, sodium zirconium cyclosilicate was associated with less need to lower or discontinue spironolactone.

Many hope My Heart Your Heart will catalyze an effort to help patients worldwide who need but can’t afford these devices.

The India-based trial, the first of its kind, confirmed that systolic BP levels decreased no matter the exact mix of three ...